Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Rika, Nagasaki"'
Autor:
Kei Ohashi, Kozue Kasukabe, Rika Nagasaki, Minoru Kokubo, Seimi Ebe, Yukie Imaizumi, Miho Hamada, Kosuke Yamamoto, Yasuhiro Rokushika
Publikováno v:
JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE. 69:535-540
Autor:
Takaharu Yamada, Mari Sugimoto, Takao Togawa, Tokio Sugiura, Yoshiaki Nagaya, Norihisa Koyama, Koichi Ito, Koya Kawase, Shinji Saitoh, Rika Nagasaki, Takenori Kato, Masanori Kouwaki
Publikováno v:
Pediatrics International. 58:461-466
Background Persistent patent ductus arteriosus (PDA) is a frequent complication in preterm infants. Single nucleotide polymorphisms (SNP) in several genes, including angiotensin II receptor, type 1 (AGTR1), transcription factor AP-2 beta (TFAP2B) and
Autor:
S. Kato, H. Ueda, N. H. Tsuno, Rika Nagasaki, Shinji Saitoh, Tokio Sugiura, Takenori Kato, Kei Ito, K. Katano, M. Matsuhashi
Publikováno v:
Transfusion Medicine. 25:42-46
SUMMARY Objective To prevent neonatal alloimmune thrombocytopenia due to anti-group A antibody perinatal management was performed. Background We previously reported a case of severe intracranial haemorrhage associated with neonatal alloimmune thrombo
Autor:
Tokio Sugiura, Sachiko Inukai, Koichi Ito, Takenori Kato, Rika Nagasaki, Shinji Saitoh, Nikiko Sato, Kazutaka Suzuki
Publikováno v:
Pediatrics International. 57:1020-1022
Tolvaptan is an oral vasopressin type 2 receptor antagonist that can be used for heart failure patients with hyponatremia or symptomatic congestion. Although the effects of tolvaptan in adults have been well documented, only limited information is av
Autor:
Takenori Kato, Shinji Saitoh, Kei Ito, T Goto, H. Ueda, Rika Nagasaki, Tokio Sugiura, E Mizutani, Risa Awaya
Publikováno v:
Europe PubMed Central
The aim of the present study was to identify predictive data on the short-term outcomes of fetuses with oligohydramnios.A retrospective study of all pregnancies diagnosed with oligohydramnios was performed.A total of 17 fetuses (seven males, seven fe
Autor:
Tokio Sugiura, Ineko Kato, Koichi Ito, Keisuke Mizuno, Tatenobu Goto, Hiroki Kakita, Satoshi Suzuki, Rika Nagasaki, Hiroko Ueda, Hajime Togari
Publikováno v:
Pediatric Neurology. 47:35-39
Periventricular leukomalacia is recognized as the leading cause of cerebral palsy in preterm infants. To clarify the prevalence of periventricular leukomalacia and cerebral palsy in Japan, a nationwide survey was performed. The prevalence of perivent
Autor:
Koya, Kawase, Tokio, Sugiura, Yoshiaki, Nagaya, Takaharu, Yamada, Mari, Sugimoto, Koichi, Ito, Takao, Togawa, Rika, Nagasaki, Takenori, Kato, Masanori, Kouwaki, Norihisa, Koyama, Shinji, Saitoh
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 58(6)
Persistent patent ductus arteriosus (PDA) is a frequent complication in preterm infants. Single nucleotide polymorphisms (SNP) in several genes, including angiotensin II receptor, type 1 (AGTR1), transcription factor AP-2 beta (TFAP2B) and tumor necr
Autor:
Satoru Shintani, Tatsuo Shirota, Masahiro Nagasaki, Seiji Kondo, Sunao Shiogama, Yasumasa Yoshizawa, Yoshiki Mukudai, Maiko Suzuki, Rika Nagasaki
The osteogenic induction of adipose-derived stem cells (ADSCs) has been regarded as an important step in bone tissue engineering. In the present study, we focused on the buccal fat pad (BFP) as a source of adipose tissue, since BFPs are encapsulated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05997ea8f8c5b4808ad4dfc76f005d80
https://europepmc.org/articles/PMC4735575/
https://europepmc.org/articles/PMC4735575/
Autor:
Naoya Fujita, Takuji Yamada, Takayasu Nomura, Yasuko Makino, Minori Murata, Manabu Takenaka, Hiroaki Murata, Miyuki Takeuchi, Rika Nagasaki, Yukie Kaneko, Tsuyoshi Ito, Machiko Shibata, Norihisa Koyama, Yoshimi Suzuki
Publikováno v:
Nihon Shoni Jinzobyo Gakkai Zasshi. 17:27-31
Autor:
Nikiko, Sato, Tokio, Sugiura, Rika, Nagasaki, Kazutaka, Suzuki, Koichi, Ito, Takenori, Kato, Sachiko, Inukai, Shinji, Saitoh
Publikováno v:
Pediatrics international : official journal of the Japan Pediatric Society. 57(5)
Tolvaptan is an oral vasopressin type 2 receptor antagonist that can be used for heart failure patients with hyponatremia or symptomatic congestion. Although the effects of tolvaptan in adults have been well documented, only limited information is av